Sens. Grassley, Durbin Submit Op-ed on Prescription Drug Costs
It's not often you hear about a proposal to lower prescription drug costs that is supported by 76 percent of Americans as well as Democratic and Republican senators,
But you have it with our bipartisan legislation to require pharmaceutical companies to disclose list prices for their medications in direct-to-consumer television advertisements. Our measure passed the
Health and Human Services Secretary
Each year, the pharmaceutical industry spends more than
These ads provide information regarding the indication for the drug, the side effects of the drug and even where to go if the drug is too expensive to obtain. The simple addition of the list price of the drug will provide patients with the necessary information to make their best health-care decision.
The addition of the list price to TV ads is the transparency needed to allow market forces to work. High prescription drug costs hurt patients by increasing their out-of-pocket spending as well as increasing insurance premiums. Taxpayers feel the pinch of high drug prices because of increased Medicare and Medicaid spending. It should not be surprising to know that the top 20 most advertised drugs on television today cost Medicare and Medicaid a combined
The pharmaceutical industry is busy at work claiming the HHS price disclosure requirement may confuse Americans. We have more faith in American patients and the health-care providers who care for them. We believe it is important to remember several key points. First, manufacturers voluntarily choose to promote their drugs to patients over the airwaves; they are not required to do so. Second, we recognize that while patients often pay different prices for the same prescription, there needs to be common understanding on prices to compare products. We agree with HHS that disclosing the list price makes sense because it is an objective and well-understood point within the supply chain, and is at the sole discretion of manufacturers to set and adjust. Third, it is important to keep in mind that list prices directly impact the amount paid by patients, such as those in high-deductible health plans, if a drug is not on a formulary or -- even more deceptively -- through higher insurance premiums because of ever-increasing drug prices.
A voluntary action by pharmaceutical companies is no substitute for price disclosure directly in ads. That is why we support HHS in this effort.
Our bipartisan policy will boost competition and help Americans struggling with outrageously high and skyrocketing drug costs. We strongly support the proposed regulation to bring transparency to prescription drug advertising as one of many necessary strategies to lower prescription drug costs. It is well-past time for drug manufacturers to level with the American public, and we applaud Secretary Azar for capitalizing on our legislative efforts to implement this common-sense policy.


Rubino, Smullen vie for 118th Assembly district seat
Habitat for Humanity rebuilds beloved librarian’s home in the Keys after Irma
Advisor News
- Survey: Most Americans still feel prosperous despite economic worries
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
More Annuity NewsHealth/Employee Benefits News
- EXPLORING INSULIN COST-SHARING CAPS FOR PATIENTS WITH PRIVATE COVERAGE
- THE AMERICAN DIABETES ASSOCIATION FIGHTS TO MAINTAIN ACCESS TO HEALTH INSURANCE
- Grand jury accuses veteran of making false disability claims that defrauded VA
- States push short-term insurance as healthcare costs climb
- Study Findings on Managed Care Are Outlined in Reports from Massachusetts General Hospital (A RUC Rescue of Primary Care?): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- FORMER PRINCE GEORGE'S COUNTY INSURANCE AGENT SENTENCED FOR FELONY INSURANCE THEFT SCHEME
- AM Best Affirms Credit Ratings of Ameriprise Financial, Inc. and Its Subsidiaries
- AM Best Takes Various Credit Rating Actions on Certain Subsidiaries of Auto-Owners Insurance Group
- AM Best Affirms Credit Ratings of Global Atlantic Financial Group Limited and Its Subsidiaries
- AM Best Downgrades Credit Ratings of CICA Life Insurance Company of America
More Life Insurance News